Clinical correlates of insulin sensitivity and its association with mortality among men with CKD stages 3 and 4

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 4, 2014, Pages 690-697

  Xu, Hong ^a,b   Huang, Xiaoyan ^a,c   Ärnlöv, Johan ^d   Cederholm, Tommy ^e   Stenvinkel, Peter ^a   Lindholm, Bengt ^a   Risérus, Ulf ^e   Carrero, Juan Jesús ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c PEKING UNIVERSITY SHENZHEN HOSPITAL   (China)

^d DALARNA UNIVERSITY   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BODY MASS; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DISEASE ASSOCIATION; ELDERLY CARE; GLOMERULUS FILTRATION RATE; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIC EUGLYCEMIC CLAMP TECHNIQUE; HYPERLIPIDEMIA; HYPERTENSION; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORTALITY; NUTRITIONAL ASSESSMENT; PROSPECTIVE STUDY; AGE; BLOOD; EPIDEMIOLOGY; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; KIDNEY; METABOLISM; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; RISK; RISK ASSESSMENT; RISK FACTOR; SEDENTARY LIFESTYLE; SEX DIFFERENCE; SMOKING; SWEDEN; TIME;

BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL; INSULIN;

AGE FACTORS; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; GLOMERULAR FILTRATION RATE; HUMANS; INSULIN; INSULIN RESISTANCE; KIDNEY; MALE; METABOLIC SYNDROME X; MULTIVARIATE ANALYSIS; ODDS RATIO; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; SEDENTARY LIFESTYLE; SEX FACTORS; SMOKING; SWEDEN; TIME FACTORS;

EID: 84903692695     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.05230513     Document Type: Article

References (37)

1. Zethelius B, Lithell H, Hales CN, Berne C: Insulin sensitivity, proinsulin and insulin as predictors of coronary heart disease. A population-based 10-year, follow-up study in 70-year old men using the euglycaemic insulin clamp. Diabetologia 48: 862–867, 2005
2. Rutter MK, Meigs JB, Sullivan LM, D’Agostino RB Sr., Wilson PW: Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. Diabetes 54: 3252–3257, 2005
3. Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, Wong TY, McNeil J, Shaw JE: Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: The Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 116: 151–157, 2007
4. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr., Spertus JA, Costa F; American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112: 2735–2752, 2005
5. Shinohara K, Shoji T, Emoto M, Tahara H, Koyama H, Ishimura E, Miki T, Tabata T, Nishizawa Y: Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease. J Am Soc Nephrol 13: 1894–1900, 2002
6. Pham H, Robinson-Cohen C, Biggs ML, Ix JH, Mukamal KJ, Fried LF, Kestenbaum B, Siscovick DS, de Boer IH: Chronic kidney disease, insulin resistance, and incident diabetes in older adults. Clin J Am Soc Nephrol 7: 588–594, 2012
7. Pham H, Utzschneider KM, de Boer IH: Measurement of insulin resistance in chronic kidney disease. Curr Opin Nephrol Hy-pertens 20: 640–646, 2011
8. Becker B, Kronenberg F, Kielstein JT, Haller H, Morath C, Ritz E, Fliser D; MMKD Study Group: Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: The mild and moderate kidney disease study. J Am Soc Nephrol 16: 1091–1098, 2005
9. de Boer IH, Katz R, Chonchol MB, Fried LF, Ix JH, Kestenbaum B, Mukamal KJ, Peralta CA, Siscovick DS: Insulin resistance, cys- tatin C, and mortality among older adults. Diabetes Care 35: 1355–1360, 2012
10. Wallace TM, Levy JC, Matthews DR: Use and abuse of HOMA modeling. Diabetes Care 27: 1487–1495, 2004
11. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: A method for quantifying insulin secretion and resistance. Am J Physiol 237: E214–E223, 1979
12. National Kidney Foundation: K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 39[2 Suppl 1]: S1–S266, 2002
13. Byberg L, Zethelius B, McKeigue PM, Lithell HO: Changes in physical activity are associated with changes in metabolic cardiovascular risk factors. Diabetologia 44: 2134–2139, 2001
14. Larsson A, Malm J, Grubb A, Hansson LO: Calculation of glo-merular filtration rate expressed in mL/min from plasma cystatin C values in mg/L. Scand J Clin Lab Invest 64: 25–30, 2004
15. Becker W: Food Habits and Intake in Sweden 1989, Uppsala, Sweden: The Swedish National Food Administration, 1994
16. Weickert MO: What dietary modification best improves insulin sensitivity and why? Clin Endocrinol (Oxf) 77: 508–512, 2012
17. Willett WC, Howe GR, Kushi LH: Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65[4 Suppl]: 1220S–1228S, 1997
18. Pollare T, Vessby B, Lithell H: Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler Thromb 11: 1192–1203, 1991
19. Meigs JB, Rutter MK, Sullivan LM, Fox CS, D’Agostino RB Sr., Wilson PW: Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 30: 1219–1225, 2007
20. Hung AM, Sundell MB, Egbert P, Siew ED, Shintani A, Ellis CD, Bian A, Ikizler TA: A comparison of novel and commonly-used indices of insulin sensitivity in African American chronic he-modialysis patients. Clin J Am Soc Nephrol 6: 767–774, 2011
21. Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T: Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis 45: 275–280, 2005
22. Landau M, Kurella-Tamura M, Shlipak MG, Kanaya A, Strotmeyer E, Koster A, Satterfield S, Simsonick EM, Goodpaster B, Newman AB, Fried LF; Health, Aging and Body Composition Study: Correlates of insulin resistance in older individuals with and without kidney disease. Nephrol Dial Transplant 26: 2814–2819, 2011
23. Cheng HT, Huang JW, Chiang CK, Yen CJ, Hung KY, Wu KD: Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly. J Clin Endocrinol Metab 97: 1268–1276, 2012
24. Nerpin E, Risérus U, Ingelsson E, Sundström J, Jobs M, Larsson A, Basu S, Arnlöv J: Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort. Diabetes Care 31: 1550–1555, 2008
25. Klein S, Burke LE, Bray GA, Blair S, Allison DB, Pi-Sunyer X, Hong Y, Eckel RH; American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Clinical implications of obesity with specific focus on cardiovascular disease: A statement for professionals from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: Endorsed by the American College of Cardiology Foundation. Circulation 110: 2952–2967, 2004
26. Plomgaard P, Bouzakri K, Krogh-Madsen R, Mittendorfer B, Zierath JR, Pedersen BK: Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation. Diabetes 54: 2939–2945, 2005
27. Basu S, Zethelius B, Helmersson J, Berne C, Larsson A, Arnlöv J: Cytokine-mediated inflammation is independently associated with insulin sensitivity measured by the euglycemic insulin clamp in a community-based cohort of elderly men. Int J Clin Exp Med 4: 164–168, 2011
28. DeCosmo S, Menzaghi C, Prudente S, Trischitta V: Role ofinsulin resistance in kidney dysfunction: Insights into the mechanism and epidemiological evidence. Nephrol Dial Transplant 28: 29–36, 2013
29. Trirogoff ML, Shintani A, Himmelfarb J, Ikizler TA: Body mass index and fat mass are the primary correlates of insulin resistance in nondiabetic stage 3-4 chronic kidney disease patients. Am J Clin Nutr 86: 1642–1648, 2007
30. Chien KL, Hsu HC, Su TC, Chen MF, Lee YT, Hu FB: Fasting and postchallenge hyperglycemia and risk of cardiovascular disease in Chinese: The Chin-Shan Community Cardiovascular Cohort study. Am Heart J 156: 996–1002, 2008
31. Bergman BC, Perreault L, Hunerdosse D, Kerege A, Playdon M, Samek AM, Eckel RH: Novel and reversible mechanisms of smoking-induced insulin resistance in humans. Diabetes 61: 3156–3166, 2012
32. Allegra V, Mengozzi G, Martimbianco L, Vasile A: Glucose-induced insulin secretion in uremia: Effects of aminophyl-line infusion and glucose loads. Kidney Int 38: 1146–1150, 1990
33. Mak RH: Insulin resistance in uremia: Effect of dialysis modality. Pediatr Res 40: 304–308, 1996
34. Liao MT, Sung CC, Hung KC, Wu CC, Lo L, Lu KC: Insulin resistance in patients with chronic kidney disease. J Biomed Bio-technol 2012: 691369, 2012
35. Stenvinkel P, Ottosson-Seeberger A, Alvestrand A: Renal hemo-dynamics and sodium handling in moderate renal insufficiency: The role of insulin resistance and dyslipidemia. J Am Soc Nephrol 5: 1751–1760, 1995
36. Cybulsky AV: Endoplasmic reticulum stress in proteinuric kidney disease. Kidney Int 77: 187–193, 2010
37. Duckworth WC, Bennett RG, Hamel FG: Insulin degradation: Progress and potential. Endocr Rev 19: 608–624, 1998